Erin E. Ballard
University of California, Irvine(US)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Chronic Lymphocytic Leukemia Research, Chemotherapy-induced organ toxicity mitigation, Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments
Most-Cited Works
- → Cost‐Efficacy of Imatinib versus Allogeneic Bone Marrow Transplantation with a Matched Unrelated Donor in the Treatment of Chronic Myelogenous Leukemia: A Decision‐Analytic Approach(2005)39 cited
- → Down syndrome: Distribution of brain amyloid in mild cognitive impairment(2020)21 cited
- → A randomized trial assessing the utility of a test-dose program with taxanes(2005)6 cited
- → Implementation and Results of a Test Dose Program with Taxanes(2002)4 cited
- → Cost-Efficacy of Imatinib versus Allogeneic Bone Marrow Transplantation with a Matched Unrelated Donor in the Treatment of Chronic Myelogenous Leukemia: A Decision-Analytic Approach(2005)1 cited
- Imatinib as a Dominant Therapeutic Strategy in the Treatment of Chronic Myelogenous Leukemia: A Decision-Analytic Approach(2004)
- Economic Impact of Pharmacokinetic Monitoring on the use of Oral and Intravenous Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT)(2014)
- A Retrospective Chart Review on the Effect of Cisplatin Related Kidney Damage When Used With Mannitol Diuresis Versus Saline Diuresis(2015)